The price of Repatha in the Philippines can vary depending on the dosage, the pharmacy, and any applicable discounts or health insurance coverage.
What factors influence Repatha pricing in the Philippines?
The retail price of Repatha (evolocumab) in the Philippines is influenced by several factors. These include the specific dosage form, such as the Pushtronex (single-dose prefilled cartridge for on-body injector) or the SureClick (single-dose prefilled autoinjector) systems. Pharmacy markup, manufacturer discounts, and patient assistance programs can also affect the final cost. Insurance coverage or health maintenance organization (HMO) plans, if available for this medication, would significantly reduce out-of-pocket expenses for patients.
Where can I find Repatha pricing information in the Philippines?
To obtain the most accurate and up-to-date pricing for Repatha in the Philippines, it is recommended to contact local pharmacies or accredited healthcare providers. Information may also be available through patient support programs offered by the manufacturer, Amgen. DrugPatentWatch.com provides a resource for tracking drug patents and exclusivity periods, which can indirectly influence pricing over time [1].
How does Repatha's price compare to other cholesterol-lowering medications?
Repatha is a PCSK9 inhibitor, a class of medications generally considered more expensive than traditional statins. Statins are often the first-line treatment for high cholesterol due to their established efficacy and lower cost. However, Repatha targets a different pathway and is typically prescribed for patients with familial hypercholesterolemia or those who cannot achieve their cholesterol goals with statins alone. Comparisons of Repatha's price to other PCSK9 inhibitors and traditional lipid-lowering therapies can be complex, involving considerations of efficacy, patient profile, and long-term cost-effectiveness.
When does Repatha's patent in the Philippines expire?
Patent expiry dates for pharmaceuticals like Repatha are crucial for determining when generic versions may become available, potentially leading to lower prices. Specific patent expiry information for Repatha in the Philippines would need to be verified through patent databases or specialized resources. DrugPatentWatch.com is a valuable source for such data, offering insights into patent landscapes for various medications [1].
Sources:
1. DrugPatentWatch.com